Nexalin Technology (NXL) Return on Sales (2022 - 2025)
Historic Return on Sales for Nexalin Technology (NXL) over the last 4 years, with Q3 2025 value amounting to 125.42%.
- Nexalin Technology's Return on Sales fell 574700.0% to 125.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 55.3%, marking a year-over-year decrease of 210000.0%. This contributed to the annual value of 45.12% for FY2024, which is 31400.0% down from last year.
- According to the latest figures from Q3 2025, Nexalin Technology's Return on Sales is 125.42%, which was down 574700.0% from 22.4% recorded in Q2 2025.
- Over the past 5 years, Nexalin Technology's Return on Sales peaked at 0.56% during Q3 2022, and registered a low of 125.42% during Q3 2025.
- In the last 4 years, Nexalin Technology's Return on Sales had a median value of 24.49% in 2023 and averaged 42.16%.
- In the last 5 years, Nexalin Technology's Return on Sales plummeted by -947100bps in 2023 and then surged by 273100bps in 2024.
- Nexalin Technology's Return on Sales (Quarter) stood at 19.08% in 2022, then tumbled by -99bps to 38.01% in 2023, then crashed by -174bps to 104.25% in 2024, then dropped by -20bps to 125.42% in 2025.
- Its Return on Sales stands at 125.42% for Q3 2025, versus 22.4% for Q2 2025 and 48.45% for Q1 2025.